Larson Financial Group LLC Grows Position in Agilent Technologies, Inc. (NYSE:A)

Larson Financial Group LLC raised its position in Agilent Technologies, Inc. (NYSE:A) by 8.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 4,437 shares of the medical research company’s stock after buying an additional 349 shares during the quarter. Larson Financial Group LLC’s holdings in Agilent Technologies were worth $596,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. CKW Financial Group boosted its stake in shares of Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares during the period. Global X Japan Co. Ltd. lifted its position in Agilent Technologies by 161.1% during the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock worth $25,000 after acquiring an additional 116 shares during the period. Ashton Thomas Securities LLC purchased a new position in shares of Agilent Technologies in the 3rd quarter valued at approximately $31,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Agilent Technologies in the third quarter valued at approximately $38,000. Finally, Hanson & Doremus Investment Management raised its stake in shares of Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after purchasing an additional 105 shares during the last quarter.

Analyst Upgrades and Downgrades

A has been the topic of a number of analyst reports. Bank of America lowered their price objective on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Robert W. Baird dropped their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Sanford C. Bernstein reduced their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. JPMorgan Chase & Co. lowered their price objective on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Finally, Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and increased their target price for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Stock Up 0.0 %

A opened at $126.59 on Monday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The company has a market cap of $36.09 billion, a price-to-earnings ratio of 29.10, a PEG ratio of 3.56 and a beta of 1.11. Agilent Technologies, Inc. has a one year low of $121.45 and a one year high of $155.35. The business’s fifty day moving average is $139.67 and its two-hundred day moving average is $138.68.

Agilent Technologies (NYSE:A) last issued its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating analysts’ consensus estimates of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. Analysts anticipate that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.78%. The ex-dividend date of this dividend is Tuesday, April 1st. Agilent Technologies’s payout ratio is currently 22.76%.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.